Progression of renal failure and hypertensive nephrosclerosis

Kidney International, Supplement

Volumn 54, Issue 68, 1998, Pages

  Zucchelli, P ^a   Zuccala, A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Atheromatous renovascular disease; Hypertension; Nephrosclerosis; Progression of renal disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; DISEASE ASSOCIATION; DISEASE COURSE; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; NEPHROSCLEROSIS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; PATHOPHYSIOLOGY; REVIEW;

DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE; NEPHROSCLEROSIS;

EID: 0031771554     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.06814.x     Document Type: Article

References (50)

1. F. Volhard T. Fahr Die bright’ sche neirenkrankheit, Klinik, Pathologie und Atlas 1914 Springer Berlin
2. United States Renal Data System Excerpts from the United States Renal Data System. 1994 Annual data report: Executive summary Am J Kidney Dis 24 Suppl 2 1994 S12 S17
3. G. D’Amico Comparability of the different registries on renal replacement therapy Am J Kidney Dis 25 1995 113 118
4. S. Klahr G. Schreiner I. Ichikawa The progression of renal disease N Engl J Med 318 1988 1657 1666
5. B.M. Brenner T.W. Meyer T.H. Hostetter Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 1982 652 659
6. L. Raij S. Azar W. Keane Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats Kidney Int 26 1984 137 143
7. S. Okuda H. Tsuruda K. Onoyama Y. Oh K. Motomura M. Fujishima Effects of hypertension on the progress and prognosis of experimental focal glomerular sclerosis Clin Sci 71 1986 23 29
8. R.C. Blantz F. Gabbai L.C. Gushwa C.B. Wilson The influence of concomitant experimental hypertension and glomerulonephritis Kidney Int 32 1987 652 666
9. J. Neugarten P. Alfino C. Langs R.G. Schacht D.S. Baldwin Nephrotoxic serum nephritis with hypertension; perfusion pressure and permselectivity Kidney Int 33 1988 53 57
10. A.K. Bidani M.N. Schwartz E.J. Lewis Renal autoregulation and vulnerability to hypertensive injury in remnant kidney Am J Physiol 252 1987 F1003 F1008
11. L.D. Dworkin M. Grosser H.D. Feiner M. Ullian M. Parker Renal vascular effects of antihypertensive therapy in uninephrectomized SHR Kidney int 35 1989 790 798
12. B.L. Riser P. Cortes X. Zhao J. Bernstein F. Dumler R.G. Narins Intraglomerular pressure and mesangial stretching stimulate extracellular matrix formation in the rat J Clin Invest 90 1992 1932 1943
13. G. Remuzzi P. Ruggenenti A. Benigni Understanding the nature of renal disease progression Kidney Int 57 1997 2 15
14. S. Klahr S. Ishidoya Y. Morrissey Role of angiotensin II in the tubulo-interstitial fibrosis of obstructive nephropathy Am J Kidney Dis 26 1995 141 146
15. H. Peters N.A. Noble Angiotensin II and L-arginine in tissue fibrosis: More than blood pressure Kidney Int 51 1997 1481 1486
16. S. Anderson H.G. Rennke B.M. Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
17. A. Imamura H.S. Mac Kenzie E.R. Lacy F.N. Hutchison W.R. Fitzbotton D.W. Ploth Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats Kidney Int 47 1995 1394 1402
18. P. Zucchelli A. Zuccalá Blood pressure control effects on the progression of chronic renal failure Renal Failure 15 1993 339 343
19. A. Stefanski K.G. Schmidt R. Waldherr E. Ritz Early increase in blood pressure and diastolic left ventricular malfunction in patients with glomerulonephritis Kidney Int 50 1996 1321 1326
20. H.H. Parving U.M. Smidt A.R. Andersen P.A.A. Svendsen Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy Lancet i 1983 1175 1177
21. T.H. Hannedouche G. Albouze P.H. Chauveau B. Lacour P. Jungers Effects of blood pressure and antihypertensive treatment of progression of advanced chronic renal failure Am J Kidney Dis 21 Suppl 2 1993 131 137
22. F. Locatelli D. Marcelli M. Comelli D. Alberti G. Graziani G. Buccianti B. Redaelli A. Giangrande the Northern Italian Cooperative Study Group Proteinuria and blood pressure as causal components of progression to end-stage renal failure Nephrol Dial Transplant 11 1996 461 467
23. S. Klahr A.S. Levey G.J. Beck A.W. Caggiula L. Hunsicker J.W. Kusec G. Striker The effect of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884
24. L.G. Hunsicker S. Adler A. Caggiula B.K. England T. Greene J.W. Kusek N.L. Rogers P.E. Teshan Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study Kidney Int 51 1997 1908 1919
25. B.L. Kasiske R.S.N. Kalil J.R. Ma M. Liao W.F. Keane Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis Ann Intern Med 118 1993 129 138
26. M. Ravid H. Savin I. Jutrin T. Bental B. Katz M. Lishner Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients Ann Intern Med 118 1993 577 581
27. E.J. Lewis L.G. Hunsicker R.P. Bain R.D. Rohde for the Collaborative Study Group The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
28. H.H. Parving P. Rossing E. Hommel U.M. Smidt Angiotensin-converting enzyme inhibition in diabetic nephropathy: Ten years’ experience Am J Kidney Dis 26 1995 99 107
29. P. Zucchelli A. Zuccalá M. Borghi M. Fusaroli M. Sasdelli C. Stallone G. Sanna R. Gaggi Long-term comparison between captopril and nifedipine in the progression of renal insufficiency Kidney Int 42 1992 452 458
30. A.-L. Kamper S. Standgaard P.P. Leyssac Effect of enalapril on the progression of chronic renal failure Am J Hypertens 5 1992 423 430
31. T. Hannedouche P. Landais B. Goldfarb N.E. El Esper A. Fournier M. Godin D. Durand J. Chanard F. Mignon J.M. Suc J.P. Grünfeld Randomized controlled trial of enalapril and β -blocker in non-diabetic chronic renal failure Br Med J 309 1994 833 837
32. B.U. Ihle J.A. Whitworth S. Shahinfar A. Cnaan P.S. Kincaid-Smith G.J. Becker Angiotensin-converting enzyme inhibition in nondiabetic progressive renal insufficiency: A controlled double-blind trial Am J Kidney Dis 27 1996 489 495
33. G. Maschio D. Alberti G. Janin F. Locatelli J.F. Mann M. Motolese C. Ponticelli E. Ritz P. Zucchelli Angiotensin-converting enzyme inhibition in progressive renal insufficiency study group: Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal insufficiency N Engl J Med 334 1996 939 945
34. J. Giatras J. Lau A.S. Lewis for the Angiotensin-Converting Enzyme Inhibition, Progressive Renal Disease Study Group Effect of Angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials Ann Intern Med 127 1997 337 345
35. K.A. Griffin M. Picken A.K. Bidani Radiotelemetric BP monitoring antihypertensives and glomeruloprotection in remnant kidney model Kidney Int 46 1994 1010 1018
36. J.C. Peterson S. Adler J.M. Burkart T. Greene L.A. Hebert L.G. Hunsicker A.J. King S. Klahr S.G. Massry J.L. Seifter for the Modification of Diet in Renal Disease (MDRD) Study Group Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease study Ann Intern Med 123 1995 754 762
37. The GISEN Group (Gruppo Italiano di Studi Epidemiologici di Nefrologia) Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy Lancet 349 1997 1857 1863
38. United States Renal Data System Annual Data Report. Incidence and prevalence of ESRD Am J Kidney Dis 30 Suppl 2 1997 S40 S53
39. P.K. Whelton M.J. Klag Hypertension as a risk factor for renal disease: Review of clinical and epidemiological evidence Hypertension 13 Suppl 1 1989 119 127
40. P. Zucchelli A. Zuccalá Hypertension and renal dysfunction Curr Opin Nephrol Hypertens 5 1996 97 101
41. P. Zucchelli A. Zuccalá Can we accurately diagnose nephrosclerosis? Nephrol Dial Transplant 10 Suppl 6 1995 2 5
42. P. Zucchelli A. Zuccalá R. Gaggi Primary hypertension as a cause of end-stage renal failure Contrib Nephrol, Basel, Karger 109 1994 70 75
43. P. Zucchelli A. Zuccalá Ischaemic nephropathy, A.M. Davison J.S. Cameron J.P. Grünfeld D.N.S. Kerr E. Ritz C.G. Vinearls Oxford Textbook of Clinical Nephrology 2nd ed 1998 Oxford University Press Oxford 1445 1456
44. A. Meyrier Renal vascular lesions in the elderly: nephrosclerosis or atheromatous renal disease? Nephrol Dial Transplant 11 Suppl 9 1996 45 52
45. A.E.G. Raine Hypertension and the kidney Brit Med Bull 50 1994 322 341
46. A. Fogo J.A. Breyer M.C. Smith W.H. Cleveland L. Agadoa K.A. Kirk R. Glassock the AASK Pilot Study Investigators Accuracy of the diagnosis of hypertensive nephrosclerosis in African American: A report from the African American: A report from the African American Study of Kidney Disease (AASK) trial Kidney Int 51 1997 244 252
47. R.E. Tracy M. Velez-Duran T. Heigle M.C. Oalmann Two variants of nephrosclerosis separately related to age and blood pressure Am J Pathol 131 1988 270 282
48. A. Zuccalá P. Zucchelli Is nephroangiosclerosis a hypertension-induced nephropathy? Contrib Nephrol, Basel, Karger 119 1996 110 114
49. J.M. Rimmer F.J. Gennari Atherosclerotic renovascular disease and progressive renal failure Ann Intern Med 118 1993 712 719
50. A. Zuccalá P. Zucchelli A renal disease frequently found at postmortem, but rarely diagnosed in vivo Nephrol Dial Transplant 12 1997 1762 1767